213 related articles for article (PubMed ID: 23363979)
1. In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signaling.
Schneider A; Long SA; Cerosaletti K; Ni CT; Samuels P; Kita M; Buckner JH
Sci Transl Med; 2013 Jan; 5(170):170ra15. PubMed ID: 23363979
[TBL] [Abstract][Full Text] [Related]
2. CD4+T-bet+, CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment.
Frisullo G; Iorio R; Plantone D; Marti A; Nociti V; Patanella AK; Batocchi AP
Mult Scler; 2011 May; 17(5):556-66. PubMed ID: 21177324
[TBL] [Abstract][Full Text] [Related]
3. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity.
Frisullo G; Angelucci F; Caggiula M; Nociti V; Iorio R; Patanella AK; Sancricca C; Mirabella M; Tonali PA; Batocchi AP
J Neurosci Res; 2006 Oct; 84(5):1027-36. PubMed ID: 16865709
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and lymphopenia trigger autoimmunity by suppression of IL-2-controlled regulatory T cell and increase of IL-21-mediated effector T cell expansion.
Chevalier N; Thorburn AN; Macia L; Tan J; Juglair L; Yagita H; Yu D; Hansbro PM; Mackay CR
J Immunol; 2014 Nov; 193(10):4845-58. PubMed ID: 25339665
[TBL] [Abstract][Full Text] [Related]
5. Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment Regimens.
Rodi M; Dimisianos N; de Lastic AL; Sakellaraki P; Deraos G; Matsoukas J; Papathanasopoulos P; Mouzaki A
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27571060
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis: T-cell resistance to regulation in RRMS linked to IL-6 pathway.
Malpass K
Nat Rev Neurol; 2013 Mar; 9(3):122. PubMed ID: 23419368
[No Abstract] [Full Text] [Related]
7. Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells.
Finotto S; Eigenbrod T; Karwot R; Boross I; Doganci A; Ito H; Nishimoto N; Yoshizaki K; Kishimoto T; Rose-John S; Galle PR; Neurath MF
Int Immunol; 2007 Jun; 19(6):685-93. PubMed ID: 17496315
[TBL] [Abstract][Full Text] [Related]
8. Effect of IFN-beta therapy on the frequency and function of CD4(+)CD25(+) regulatory T cells and Foxp3 gene expression in relapsing-remitting multiple sclerosis (RRMS): a preliminary study.
Namdar A; Nikbin B; Ghabaee M; Bayati A; Izad M
J Neuroimmunol; 2010 Jan; 218(1-2):120-4. PubMed ID: 19932513
[TBL] [Abstract][Full Text] [Related]
9. Role of IL-16 in CD4+ T cell-mediated regulation of relapsing multiple sclerosis.
Skundric DS; Cruikshank WW; Drulovic J
J Neuroinflammation; 2015 Apr; 12():78. PubMed ID: 25896927
[TBL] [Abstract][Full Text] [Related]
10. CD4+CD25+FoxP3+PD1- regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy.
Saresella M; Marventano I; Longhi R; Lissoni F; Trabattoni D; Mendozzi L; Caputo D; Clerici M
FASEB J; 2008 Oct; 22(10):3500-8. PubMed ID: 18587005
[TBL] [Abstract][Full Text] [Related]
11. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
[TBL] [Abstract][Full Text] [Related]
12. miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis.
Ahmadian-Elmi M; Bidmeshki Pour A; Naghavian R; Ghaedi K; Tanhaei S; Izadi T; Nasr-Esfahani MH
Immunogenetics; 2016 Jan; 68(1):43-54. PubMed ID: 26563334
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T cells fail to suppress CD4T+-bet+ T cells in relapsing multiple sclerosis patients.
Frisullo G; Nociti V; Iorio R; Patanella AK; Caggiula M; Marti A; Sancricca C; Angelucci F; Mirabella M; Tonali PA; Batocchi AP
Immunology; 2009 Jul; 127(3):418-28. PubMed ID: 19016907
[TBL] [Abstract][Full Text] [Related]
14. Differential reconstitution of T cell subsets following immunodepleting treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with relapsing-remitting multiple sclerosis.
Zhang X; Tao Y; Chopra M; Ahn M; Marcus KL; Choudhary N; Zhu H; Markovic-Plese S
J Immunol; 2013 Dec; 191(12):5867-74. PubMed ID: 24198283
[TBL] [Abstract][Full Text] [Related]
15. CD127 immunophenotyping suggests altered CD4+ T cell regulation in primary progressive multiple sclerosis.
McKay FC; Swain LI; Schibeci SD; Rubio JP; Kilpatrick TJ; Heard RN; Stewart GJ; Booth DR
J Autoimmun; 2008 Aug; 31(1):52-8. PubMed ID: 18406576
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T cell proliferative potential is impaired in human autoimmune disease.
Carbone F; De Rosa V; Carrieri PB; Montella S; Bruzzese D; Porcellini A; Procaccini C; La Cava A; Matarese G
Nat Med; 2014 Jan; 20(1):69-74. PubMed ID: 24317118
[TBL] [Abstract][Full Text] [Related]
17. T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis.
Iorio R; Frisullo G; Nociti V; Patanella KA; Bianco A; Marti A; Mirabella M; Tonali PA; Batocchi AP
Clin Immunol; 2009 Apr; 131(1):70-83. PubMed ID: 19097824
[TBL] [Abstract][Full Text] [Related]
18. Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression.
Hundhausen C; Roth A; Whalen E; Chen J; Schneider A; Long SA; Wei S; Rawlings R; Kinsman M; Evanko SP; Wight TN; Greenbaum CJ; Cerosaletti K; Buckner JH
Sci Transl Med; 2016 Sep; 8(356):356ra119. PubMed ID: 27629486
[TBL] [Abstract][Full Text] [Related]
19. Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppression.
Goodman WA; Young AB; McCormick TS; Cooper KD; Levine AD
J Immunol; 2011 Mar; 186(6):3336-45. PubMed ID: 21307288
[TBL] [Abstract][Full Text] [Related]
20. Serum Th17 cytokines in leprosy: correlation with circulating CD4(+) CD25 (high)FoxP3 (+) T-regs cells, as well as down regulatory cytokines.
Attia EA; Abdallah M; El-Khateeb E; Saad AA; Lotfi RA; Abdallah M; El-Shennawy D
Arch Dermatol Res; 2014 Nov; 306(9):793-801. PubMed ID: 25018055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
